About this item
Product details
Empaphage (Empagliflozin) Tablets by Martin Dow is a prescription medication belonging to the class of SGLT2 inhibitors (sodium-glucose cotransporter-2 inhibitors). It is indicated for the management of type 2 diabetes mellitus, as well as for reducing the risk of cardiovascular death and hospitalization for heart failure in adults. Available in a targeted 25mg strength, Empaphage works by blocking glucose reabsorption in the kidneys, promoting the excretion of excess sugar through urine. This action helps lower blood glucose levels while providing significant renal and cardiovascular protective benefits Effective Blood Sugar Control: Contains Empagliflozin, a potent SGLT2 inhibitor designed to help manage type 2 diabetes by effectively lowering elevated blood glucose levels Cardiovascular & Renal Protection: Proven to provide protective benefits to the heart and kidneys, helping to reduce the risk of cardiovascular death and hospitalization for heart failure in adults Composition Each film-coated tablet contains: Empagliflozin, MDM: 25 mg Directions for Use Use only as directed by the physician or see package insert
- Medicines
- Default Title
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Martin Dow
- SKU
- 08964001519249
- Variant
- Default Title
- Tags
- Empagliflozin, Medicine
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
